Bristol Myers Squibb stock surges on dual phase 3 clinical trial successes

5 ETFs I'm Buying and Holding Through the Next Bear Market and Beyond

NASDAQ · Markets 13m ago

AxoGen stock initiated at Buy by BofA on growth outlook

Investing.com · News 13m ago

BofA raises Helmerich & Payne stock price target to $46 on tech edge

Investing.com · News 13m ago

BofA cuts Insmed stock price target on valuation concerns

Investing.com · News 13m ago

BofA raises Gilead Sciences stock price target on growth outlook

Investing.com · News 13m ago

BofA cuts Vertex stock price target to $667 on CF franchise outlook

Investing.com · News 13m ago

HSBC Moves to Wall Street Bonus Model

Bloomberg · Markets Video 14m ago

4 Years Into the Bull Market

Investing.com · Overview 14m ago

UBS sees scope for milder UK budget as markets focus on fiscal credibility

Investing.com · News 14m ago

UBS sees scope for milder UK budget as markets focus on fiscal credibility

Investing.com · Investing_news 14m ago